Monday August 10, 2026 4:05 PM ET

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel

Wednesday August 5, 2026 4:05 PM ET

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook

Wednesday July 15, 2026 4:05 PM ET

QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak

Wednesday July 15, 2026 8:48 AM ET

QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast

Tuesday July 14, 2026 4:05 PM ET

QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe

Monday June 15, 2026 1:30 AM ET

QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma

Thursday May 28, 2026 4:05 PM ET

QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak

Wednesday May 20, 2026 4:05 PM ET

QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows

Tuesday May 19, 2026 4:05 PM ET

QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA

Tuesday May 12, 2026 2:00 AM ET

QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting

Thursday May 7, 2026 6:00 AM ET

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

Wednesday May 6, 2026 4:05 PM ET

QIAGEN Reports Full Results for Q1 2026

Monday April 27, 2026 4:16 PM ET

QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

Thursday April 16, 2026 4:05 PM ET

QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026

Tuesday April 14, 2026 4:05 PM ET

QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel

Friday March 20, 2026 7:30 AM ET

Qiagen Announces Form 20-F Annual Report Filing for 2025 Results

Thursday March 19, 2026 4:05 PM ET

QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention

Tuesday March 10, 2026 5:05 PM ET

QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System